Publications by authors named "Zhijie Ding"

Claim this Profile
C
Compositional and structural control toward boosting inner-grain prestress and releasing the inter-lattice strain of an FGH99 diffusion-bonded superalloy.
Xiaolong Hong, Zhiwei Qin, Xin Jiang, Jilong Wang, Jiachen Li, Zhijie Ding

Mater Horiz· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexible and elastic chitosan-based hydrogel film dressings for second-degree partial-thickness burn wound healing.
Zifeng Zhang, Yingjie Zhang, Daqing Pan, Fei Wang, Gaoya Hao, Zhijie Ding

J Mater Sci Mater Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomic hysteretic diffusion enables high-strength TiAl/Ni joints cluster-plus-glue-atom modeled GCFMs.
Liangliang Zhang, Weimin Long, Peng Li, Zhiwei Qin, Zhijie Ding

Mater Horiz· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8 T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma.
Wenbo Jia, Jinyi Wang, Weiming Yang, Zhijie Ding, Litao Liang, Wenzhou Ding

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Match-Adjusted Comparative Analysis.
Javier Munoz, Allison Rosenthal, Andrew Ip, Justin M Darrah, Tongsheng Wang, Zhijie Ding

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical representativeness of pivotal trials for T-cell engagers in relapsed/refractory follicular lymphoma.
Zhijie Ding, Guihua Zhang, Junhua Yu, Tongsheng Wang, Rajesh Kamalakar

Future Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL.
John N Allan, Tao Ran, Zhijie Ding, Jinghua He, Alex Bokun

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma.
Alexey V Danilov, Swetha Kambhampati Thiruvengadam, Kim Linton, Karen Cumings, Viktor Chirikov, Zhijie Ding

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermokinetic Characteristics of Coal by Multi Kinetics Methods and TG-MS and TG-DSC-FTIR: A Case of the Dananhu Second Mine of Xinjiang.
Jianling Zang, Jinsheng Zhao, Wei Sun, Zhenkai Yang, Zhijie Ding

ACS Omega· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases.
Kerry A Rogers, Benyam Muluneh, Zaina P Qureshi, Jinghua He, Alex Bokun, Zhijie Ding

J Comp Eff Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers.
Xuehui Hong, He Huang, Xingfeng Qiu, Zhijie Ding, Xing Feng

Elife· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of healthy eating index-2015 in the associations of biological aging and non-alcoholic fatty liver disease: an interaction and mediation analysis.
Xiang Zhang, Zhijie Ding, Yong Yan, Weiming Yang, Xiaoming Ai

J Health Popul Nutr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NeuroPpred-SHE: An interpretable neuropeptides prediction model based on selected features from hand-crafted features and embeddings of T5 model.
Jian Wen, Zhijie Ding, Zhuoyu Wei, Hongwei Xia, Yong Zhang

Comput Biol Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strain-Mediated Defect Engineering toward Rapid Atomic Migration in Fe-Al Diffusion Couples.
Zhijie Ding, Peng Li, Zhiwei Qin, Weiben Huang, Peng Zhao

Nano Lett· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
Huabin Hu, Jianwei Zhang, Yunfeng Li, Xiaozhong Wang, Ziqiang Wang, Kefeng Ding, Zhijie Ding

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ibrutinib dose adjustment on TTNT in first-line CLL/SLL: a real-world analysis using target trial emulation.
Nilanjan Ghosh, Ruibin Wang, Zaina P Qureshi, Zhijie Ding, Marie-Hélène Lafeuille

Blood Neoplasia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulus-Response Patterns: The Key to Giving Generalizability to Text-Based Depression Detection Models.
Zhenyu Liu, Yang Wu, Haibo Zhang, Gang Li, Zhijie Ding

IEEE J Biomed Health Inform· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis.
Maryia Zhdanava, Sumesh Kachroo, Aditi Shah, Zhijie Ding, Patrick Lefebvre

Patient Prefer Adherence· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and clinical burden of chronic corticosteroid use in patients with Crohn[apos]s disease initiated on biologic or conventional therapies in the US: A retrospective claims study.
Maryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, Zhijie Ding, Julien Boudreau

J Am Pharm Assoc (2003)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative long-term outcomes of natural orifice specimen extraction surgery and conventional laparoscopic colectomy for left-sided colorectal cancer: a propensity score-matched analysis.
Shu-Zhen Xu, Zhen-Fa Wang, Zhi-Jie Ding, Shi-Feng Zhang, Si-Bo Yuan

Int J Surg· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States.
Maryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, Zhijie Ding, Julien Boudreau

J Manag Care Spec Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-Up.
Ruizhi Zhao, Zhijie Ding, Parul Gupta, Laurence Gozalo, Robert Bruette

J Health Econ Outcomes Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic study of in response to salt and drought stress.
Zhijie Ding, Zhiyou Liu, Jinbo Bao, Yuwei Wang, Jialei Li

Funct Plant Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholecystectomy Significantly Alters Gut Microbiota Homeostasis and Metabolic Profiles: A Cross-Sectional Study.
Fusheng Xu, Ruimin Chen, Chengcheng Zhang, Hao Wang, Zhijie Ding

Nutrients· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term persistence and other treatment patterns among bio-naïve patients with Crohn's disease treated with ustekinumab or adalimumab.
Maryia Zhdanava, Zhijie Ding, Ameur M Manceur, Ruizhi Zhao, Christopher Holiday

Curr Med Res Opin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis